Advertisement

Research Article Free access | 10.1172/JCI1235

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

A Okuno, H Tamemoto, K Tobe, K Ueki, Y Mori, K Iwamoto, K Umesono, Y Akanuma, T Fujiwara, H Horikoshi, Y Yazaki, and T Kadowaki

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Okuno, A. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Tamemoto, H. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Tobe, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Ueki, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Mori, Y. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Iwamoto, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Umesono, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Akanuma, Y. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Fujiwara, T. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Horikoshi, H. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Yazaki, Y. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan.

Find articles by Kadowaki, T. in: JCI | PubMed | Google Scholar

Published March 15, 1998 - More info

Published in Volume 101, Issue 6 on March 15, 1998
J Clin Invest. 1998;101(6):1354–1361. https://doi.org/10.1172/JCI1235.
© 1998 The American Society for Clinical Investigation
Published March 15, 1998 - Version history
View PDF
Abstract

Troglitazone (CS-045) is one of the thiazolidinediones that activate the peroxisome proliferator-activated receptor gamma (PPARgamma), which is expressed primarily in adipose tissues. To elucidate the mechanism by which troglitazone relieves insulin resistance in vivo, we studied its effects on the white adipose tissues of an obese animal model (obese Zucker rat). Administration of troglitazone for 15 d normalized mild hyperglycemia and marked hyperinsulinemia in these rats. Plasma triglyceride level was decreased by troglitazone in both obese and lean rats. Troglitazone did not change the total weight of white adipose tissues but increased the number of small adipocytes (< 2,500 micron2) approximately fourfold in both retroperitoneal and subcutaneous adipose tissues of obese rats. It also decreased the number of large adipocytes (> 5,000 micron2) by approximately 50%. In fact, the percentage of apoptotic nuclei was approximately 2.5-fold higher in the troglitazone-treated retroperitoneal white adipose tissue than control. Concomitantly, troglitazone normalized the expression levels of TNF-alpha which were elevated by 2- and 1.4-fold in the retroperitoneal and mesenteric white adipose tissues of the obese rats, respectively. Troglitazone also caused a dramatic decrease in the expression levels of leptin, which were increased by 4-10-fold in the white adipose tissues of obese rats. These results suggest that the primary action of troglitazone may be to increase the number of small adipocytes in white adipose tissues, presumably via PPARgamma. The increased number of small adipocytes and the decreased number of large adipocytes in white adipose tissues of troglitazone-treated obese rats appear to be an important mechanism by which increased expression levels of TNF-alpha and higher levels of plasma lipids are normalized, leading to alleviation of insulin resistance.

Version history
  • Version 1 (March 15, 1998): No description
Advertisement
Advertisement